http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101915454-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2278 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 |
| filingDate | 2010-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101915454-B1 |
| titleOfInvention | Pharmaceutical composition comprising a glp-1 agonist and methionine |
| abstract | A liquid composition comprising a GLP-1 agonist, and / or a pharmacologically acceptable salt thereof, and optionally at least one pharmaceutically acceptable excipient, wherein the composition comprises, as appropriate, methionine, metformin as an add- / Or long acting insulin / insulin derivatives. |
| priorityDate | 2009-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 169.